|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01498 PURAPHARM
Nominal 
0.270 0.000 (0.000%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 159,673 | -7.326% | 336,113 | 382,090 | 406,859 | 448,069 |
| Cost of Sales | (67,359) | -12.716% | (155,957) | (176,948) | (190,230) | (185,365) |
| Gross Profit | 92,314 | -2.953% | 180,156 | 205,142 | 216,629 | 262,704 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | (2,423) | (12,804) | (3,022) | |
| Change in FV & Impairment on Others | -- | -- | 6,866 | 997 | (8,083) | (11,906) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (134) | -- | (88) | (312) | (145) | 0 | |
| Profit / (Loss) before Taxation | (13,887) | -32.212% | (34,410) | (29,144) | (102,312) | (119,182) | |
| Taxation | (357) | -72.955% | (813) | (6,295) | (3,769) | (1,032) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (14,244) | -34.679% | (35,223) | (35,439) | (106,081) | (120,214) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 10,535 | 15.162% | 20,683 | 23,365 | 27,114 | 23,708 |
| Depreciation & Amortisation | 20,878 | 3.096% | 44,526 | 54,586 | 48,591 | 48,661 |
| Directors' Emoluments | -- | -- | -- | 7,259 | 11,677 | 7,354 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -2.660 | -51.812% | -8.410 | -8.970 | -26.850 | -30.470 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.068 | 0.263 | 0.202 | 0.224 |
| NBV per share ($) | 0.233 | -- | 0.243 | 0.281 | 0.387 | 0.652 |
| Remarks: | Real time quote last updated: 04/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -14,244 |
| %Change | -34.679% |
| EPS / (LPS) | HKD -0.027 |
| NBV Per Share ($) | HKD 0.233 |